Exact Sciences Corporation

Exact Sciences Corporation is a molecular diagnostics company focused on the development of a non-invasive screening technology to be used for the early detection and prevention of colorectal pre-cancer and invasive cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

Company Details:

Company Symbol: EXAS
Sector: Medical Devices
Company Rating: sell
URL: http://www.exactsciences.com/

Related Research

  • 05/02/12 Morning Note B. Riley & Co. Morning Notes: BEBE, EGHT, EXAR, EXAS, FEIC, HOTT, KEYN, KSWS, MYGN, OPLK, PII, PRGX, RBCN, RGC, SIMG, WWWW
  • 05/02/12 Update EXAS (Sell; $5.00 PT): Cash utilization spikes with Deep-C trial enrollment on track for completion in Q3. Timing miss-match of expectations vs. execution…
  • 02/24/12 Morning Note B. Riley & Co. Morning Notes: AXTI, CSGP, CSTR, DRCO, EXAS, IMAX, JACK, LOOP, PRGX, SIMO, UEIC, VRML
  • 02/24/12 Update EXAS (Sell; $5.00 PT): EXAS hosts Q4 conference call; provides update on Deep-C trial and operational spend for 2012; Current valuation leaves us…
  • 01/23/12 Morning Note B. Riley & Co. Morning Notes: AEO, CKEC, CNK, CYN, DRL, EWBC, EXAS, MPAA, OMEX, PII, PPC, PVSW, RGC, SHOO, SYMM, YHOO
  • 01/23/12 Initiation of Coverage EXAS (Sell; $5.00 PT): Priced for perfection while significant hurdles remain; Initiating with Sell rating and $5 PT